Ye Wei

6.9k total citations · 1 hit paper
213 papers, 4.6k citations indexed

About

Ye Wei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ye Wei has authored 213 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 48 papers in Molecular Biology. Recurrent topics in Ye Wei's work include Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Colorectal Cancer Treatments and Studies (39 papers) and Colorectal Cancer Surgical Treatments (26 papers). Ye Wei is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Colorectal Cancer Treatments and Studies (39 papers) and Colorectal Cancer Surgical Treatments (26 papers). Ye Wei collaborates with scholars based in China, United States and Hong Kong. Ye Wei's co-authors include Li Ren, Jianmin Xu, Dexiang Zhu, Xinyu Qin, Guodong He, Lechi Ye, Jianmin Xu, Meiling Ji, Wenju Chang and Qi Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ye Wei

201 papers receiving 4.5k citations

Hit Papers

Robotic versus laparoscopic surgery for middle and low re... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Wei China 36 1.9k 1.3k 1.3k 1.2k 692 213 4.6k
Daniel Neureiter Austria 42 1.5k 0.8× 2.1k 1.6× 906 0.7× 1.2k 1.0× 863 1.2× 241 5.9k
Bo Li China 36 989 0.5× 1.9k 1.4× 888 0.7× 890 0.8× 501 0.7× 238 4.3k
Hidenori Takahashi Japan 45 1.9k 1.0× 2.0k 1.5× 622 0.5× 2.2k 1.9× 1.6k 2.3× 432 7.8k
Su Jin Lee South Korea 40 1.7k 0.9× 1.7k 1.3× 681 0.5× 875 0.8× 1.4k 2.1× 272 6.2k
Fausto Sessa Italy 46 4.2k 2.2× 1.6k 1.2× 920 0.7× 2.2k 1.9× 1.1k 1.6× 204 7.7k
Yifan Wang China 37 2.4k 1.3× 3.0k 2.3× 1.1k 0.8× 604 0.5× 870 1.3× 194 7.1k
Keiji Inoue Japan 39 1.7k 0.9× 2.1k 1.6× 1.0k 0.8× 1.6k 1.4× 2.1k 3.0× 249 5.9k
Haitao Zhao China 43 2.2k 1.2× 3.3k 2.5× 2.7k 2.0× 1.6k 1.4× 1.4k 2.0× 359 8.0k
Junji Kato Japan 38 967 0.5× 1.7k 1.3× 416 0.3× 937 0.8× 707 1.0× 197 5.5k
Lizhi Zhang United States 47 3.0k 1.6× 1.9k 1.4× 720 0.5× 4.9k 4.3× 1.1k 1.6× 186 9.1k

Countries citing papers authored by Ye Wei

Since Specialization
Citations

This map shows the geographic impact of Ye Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wei more than expected).

Fields of papers citing papers by Ye Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wei. The network helps show where Ye Wei may publish in the future.

Co-authorship network of co-authors of Ye Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Wei. A scholar is included among the top collaborators of Ye Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Wei. Ye Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Mingdian, Ye Wei, Yi Liu, et al.. (2025). Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling. British Journal of Pharmacology. 182(22). 5517–5535. 1 indexed citations
2.
Liu, Menghao, et al.. (2025). Global research trends of peripheral nerve surgery: a bibliometric and visualized analysis. Neurosurgical Review. 48(1). 429–429. 1 indexed citations
3.
He, Guodong, Weitang Yuan, Taiyuan Li, et al.. (2025). Influence of surgical start time on the quality of surgery for middle and low rectal cancer: a post hoc analysis of the real trial. International Journal of Surgery. 111(5). 3281–3288.
6.
Wei, Ye, Bo Shen, Qizhu Tang, et al.. (2024). Identification of a novel immune infiltration-related gene signature, MCEMP1, for coronary artery disease. PeerJ. 12. e18135–e18135.
7.
Li, Saini, Muzi Zhu, Ye Wei, et al.. (2024). Role of tri18 gene in Epiroridin E production and toxin resistance mechanisms in Paramyrothecium roridum. International Journal of Biological Macromolecules. 280(Pt 2). 135746–135746. 1 indexed citations
8.
Wei, Ye, et al.. (2024). Long Non-Coding RNA B3GALT5-AS1 Suppresses Keloid Progression by Regulating the β-Trcp1-Mediated Ubiquitination of HuR. Clinical Cosmetic and Investigational Dermatology. Volume 17. 967–979.
9.
Chang, Wenju, Yijiao Chen, Li Ren, et al.. (2023). Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study. International Journal of Surgery. 109(10). 3070–3077. 2 indexed citations
10.
Zhu, Yingshuang, Yeting Hu, Xiangxing Kong, et al.. (2021). Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China. BMJ Open. 11(12). e051397–e051397. 1 indexed citations
11.
Wei, Ye, Saini Li, Shuai Liu, et al.. (2021). Characterization of novel gliotoxin biosynthesis-related genes from deep-sea-derived fungus Geosmithia pallida FS140. Biochimie. 191. 1–10. 6 indexed citations
12.
Feng, Qingyang, Wenju Chang, Yihao Mao, et al.. (2019). Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clinical Cancer Research. 25(13). 3896–3907. 104 indexed citations
13.
Zeng, Rong, Xiaojun Song, Changwei Liu, & Ye Wei. (2019). LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway.. PubMed Central. 11(12). 7441–7448. 21 indexed citations
14.
Jiang, Yinghao, et al.. (2019). ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 35(2). 153–162. 15 indexed citations
15.
Stany, Michael P., Pamela Stone, Janine F. Felix, et al.. (2015). Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival. International Journal of Gynecological Pathology. 34(4). 379–384. 14 indexed citations
16.
Ye, Lechi, Tianshu Liu, Li Ren, et al.. (2013). Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases. Journal of Clinical Oncology. 31(16). 1931–1938. 296 indexed citations
17.
Zhu, Dexiang, Jie Wang, Li Ren, et al.. (2012). Serum proteomic profiling for the early diagnosis of colorectal cancer. Journal of Cellular Biochemistry. 114(2). 448–455. 23 indexed citations
18.
Ren, Li, et al.. (2011). The clinical study of chemically-modified chitosan anti-adhesion film in the prevention of postoperative intra-abdominal adhesion. Zhonghua putong waike zazhi. 26(5). 414–416. 1 indexed citations
19.
Wei, Ye, et al.. (2009). [The epidemiology of dentine hypersensitivity among adults in Shanghai municipality].. PubMed. 18(3). 247–50. 8 indexed citations
20.
Mori, Rintaro, Qingcai Wang, Marcus L. Quek, et al.. (2008). Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.. PubMed. 28(1B). 425–30. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026